Administration of inhaled medication via a tracheostomy in infants with chronic lung disease of prematurity

Author： Subhedar N. V.   Doyle C.   Shaw N. J.  

Publisher： Informa Healthcare

ISSN： 1464-5270

Source： Pediatric Rehabilitation, Vol.3, Iss.2, 1999-04, pp. : 41-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Functional and Antigenic Concentrations of Alpha-1-Proteinase Inhibitor after Administration for the Prevention of Chronic Lung Disease of Prematurity

By  

Neonatology, Vol. 76, Iss. 3, 1999-08 ,pp. : 134-143

Karger

Access to resources Recommend Favorite

Angiogenesis in Lung Development, Injury and Repair: Implications for Chronic Lung Disease of Prematurity

By  

Neonatology, Vol. 91, Iss. 4, 2007-06 ,pp. : 291-297

Karger

Access to resources Recommend Favorite

Lung Microvascular Adaptation in Infants with Chronic Lung Disease

By  

Neonatology, Vol. 85, Iss. 4, 2004-06 ,pp. : 273-282

Karger

Access to resources Recommend Favorite

Chronic Lung Disease of Prematurity: Long-Term Respiratory Outcome

By  

Neonatology, Vol. 105, Iss. 4, 2014-05 ,pp. : 352-356

Karger

Access to resources Recommend Favorite

Role of Interleukin-6, Its Receptor and Soluble gp130 in Chronic Lung Disease of Prematurity

By  

Neonatology, Vol. 104, Iss. 3, 2013-07 ,pp. : 161-167

Karger

Access to resources Recommend Favorite